Targeted conditioning

Ninety-five percent of patients had a grade 3 or 4 toxicity from the conditioning, not from the gene therapy.

Eighty-six percent developed mucositis.2 The cause was the busulfan that prepared them for a curative treatment for sickle cell disease.

95%1
of gene therapy patients had a grade 3 or 4 toxicity from the conditioning
86%2
developed mucositis

Curative cell and gene therapies are gated by a fifty-year-old chemotherapy regimen. Removing that gate opens them to everyone currently too old or too fragile to qualify.

Please note: Calanova Sciences operates in a stealth capacity.

We read what comes in and answer where we can. Your details are kept to reply to you and for nothing else. Data.